Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Sioux Falls, SD
NPI: 1184743148Primary Practice Location
SANFORD USD MEDICAL CENTER
1600 W 22nd St, Sioux Falls, SD
Primary Employer
Sanford Clinic
sanfordhealth.org
HQ Phone
Get M.D. Keely's Phone Numberphone_androidMobile
Get M.D. Keely's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNE State Medical License
NE State Medical License
SD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 168 | 272 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 71 | 77 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 48 | 102 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 39 | 75 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 20 | 20 |
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Authors: Evan Pisick, Nitin Rohatgi, Rebecca Arend, Philip Gold, Olatunji Alese, Vi Chiu, Arthur Winer, Funda Meric, Richard Schilsky, Ramya Thota, Alissa Marr
Publication Date: 2023-12-01
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study.
Authors: Miroslaw Mazurczak, Steven Powell, Jonathan Bleeker, Preston Steen, Mark Gitau
Publication Date: 2018-11-01
Lead Sponsor: Washington University School of Medicine
Collaborators: Celgene Corporation
Intervention / Treatment: DRUG: Carboplatin, BIOLOGICAL: Cetuximab, DRUG: Cisplatin, DRUG: nab-paclitaxel
Lead Sponsor: Washington University School of Medicine
Collaborators: Celgene Corporation
Intervention / Treatment: BIOLOGICAL: Cetuximab, DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: nab-Paclitaxel
